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ABSTRACT
There is strong interest among payers to identify emerging health-
care cost drivers to support early intervention. However, many
challenges arise in analyzing large, high dimensional, and noisy
healthcare data. In this paper, we propose a systematic approach
that utilizes hierarchical and multi-resolution search strategies us-
ing enhanced statistical process control (SPC) algorithms to sur-
face high impact cost drivers. Our approach aims to provide in-
terpretable, detailed, and actionable insights of detected change
patterns attributing to multiple demographic and clinical factors.
We also proposed an algorithm to identify comparable treatment
offsets at the population level and quantify the cost impact on their
utilization changes.
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1 INTRODUCTION
There is strong interest to better understand and manage drivers of
healthcare cost. Payers, including public agencies, private health
plans, and self-insured employers, are particularly interested in
identifying emerging cost drivers to support early intervention.
Traditional approaches to identify cost drivers within large payer
claims databases can be labor-intensive. It may require manually
drilling into the data, and often times, drivers exhibit insidious
trends, are masked within summary reports, or are too general to
deem actionable.
Data scientists tasked with cost driver detection can be over-
whelmed by the sheer volume of data. Their analysis may be driven
by personal experience which could bias their approach to perform
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a systematic and comprehensive detection. Furthermore, several fac-
tors make analyzing healthcare claims data a challenge. First, claims
data is high dimensional and sparse with noisy signal strength. Sec-
ond, data collection and standardization can be inconsistent across
data sources, due to variation in clinical coding practices, health-
care delivery and payment models, and speed of claims processing.
Third, healthcare cost drivers tend to be inter-related, making it
difficult to isolate the underlying root cause. Finally, healthcare cost
changes could be influenced by seasonal factors, clinical guidelines,
or new technologies introduced to the market. These considera-
tions make it challenging for data scientists and payers to determine
where to efficiently focus their efforts on.
In this paper, we introduce a statistical process control (SPC)-
based detection algorithm to identify emerging healthcare cost
drivers. Applications to SPC have been used in many healthcare
domains[9–11]. However, existing studies have been limited to a
specific outcome within a target population (e.g., inpatient read-
mission rates for an individual hospital).
Instead of looking at a particular condition or treatment, our
approach performs an exhaustive search. We utilize hierarchical
and multi-resolution schemes to characterize the temporal change
patterns and attribute the changes to multiple explanatory factors.
Compared to other cost attribution studies[8], we leverage clinical
episode-based groupings and multi-factor drill downs for better
interpretability. We also propose an algorithm to monitor “utiliza-
tion offsets” of comparable treatments and estimate the cost impact
attributed to the offset effect. Utilization offsets or treatment switch
analyses have been studied extensively within real-world evidence
applications[1]. Our approach extends this concept to evaluate the
cost impact of offsets for drug treatments, disease severity, as well
as care setting.
2 SEARCH STRATEGIES
We apply hierarchical and multi-resolution search strategies lever-
aging domain knowledge-based factors to search for impactful cost
drivers. The claims data is aggregated into multiple key perfor-
mance indicator (KPI) time series based on (1) different hierarchical
drill paths or “viewpoints” and (2) time horizon settings.
We use a 1 million random sample of enrollees from the IBMWat-
son Health MarketScan Commercial Database [6] from 2012-2016.
The database includes a longitudinal perspective of enrollment,
demographic, medical and pharmacy claims data from large em-
ployers and health plans. The claims data provides demographic and
clinical information (e.g., diagnoses, procedures, drug codes, care
setting, etc.) and cost information associated with the healthcare
services. We also utilize medical groupers that combines medical
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and pharmacy claims into unique episodes of care which allows
us to tie drug information to specific conditions [7]. Finally, we
use the Micromedex RED BOOK database to establish a knowledge
base of comparable drug treatments for the offsets identification
algorithm[5].
The claims data is grouped into clinical episodes of care by as-
signing an event label (e.g., treatment episodes, admissions) to
each claim record. The records are then aggregated according to
viewpoint definitions. Figure 1 shows an example of different view-
points based on demographic and clinical attributes. For example, a
viewpoint pertaining to a specific condition, pharmacy claim type,
therapeutic class, and drug product name hierarchy will provide
insights on a specific drug for treating a specific condition. This can
also be extended to inpatient and outpatient claims and their re-
lated attributes (e.g., procedure, provider specialty, place of service,
geography, etc.).
Figure 1: Example of Viewpoint Hierarchy
Data are also aggregated temporally using multiple analysis win-
dows with different durations and resolutions as shown in Figure
2. Changes are detected based on year-to-year comparisons of the
KPIs while controlling for lags in payment processing over time.
Figure 2: Example of Multi-Resolution Analysis
Various KPIs are computed for the time series. For each viewpoint
and time period combination, we calculate the total cost, number
of episodes, number of enrollees, number of patients with a specific
condition, number of claimants on a specific treatment, and quantity
of services. This provides information to calculate the ratios for
each KPI and standard errors shown in Figure 3.
Figure 3: Example of KPI Decomposition
3 CHANGE PATTERN LEARNING
3.1 Detect Change Patterns
To detect changes early, reliably, and in a clinically meaningful
manner, we developed an enhanced SPC-based analytics algorithm
incorporating domain hierarchical knowledge. It contains three
primary functionalities: a threshold learning module to establish
a detection threshold through historical data modeling, an online
detection mechanism (e.g., auto-reset or non-restarting CUSUM
[2, 3]), and a change pattern reporting rules engine.
The enhanced SPC-based algorithms use one or more detection
thresholds to control the false detection rate. Detection thresholds
are learned via simulation to account for sampling errors and pos-
sible serial dependence of change rates. For example, statistical
time series models (e.g., ARMA, Gaussian white noise, etc.) for
normalized rates of change could be used to simulate time series
data for different KPIs under the hypothesis of no change. We run
the SPC-based change detection algorithms over each simulated
time series for each value in the set of trail thresholds. The fraction
of detected cases (false alarm rate) are then computed for each trial
threshold value. The threshold whose false alarm rate is closest to
the target false alarm rate is identified.
The online detection algorithms automatically account for multi-
ple change points. By specifying reporting rules, changes detected
can be reported at any point within the analysis window, or re-
ported at the end of the analysis to focus on the latest cumulative
effect of change. Figure 4 shows an example of enhanced SPC algo-
rithms with learned detection thresholds. High and low thresholds
for upward and downward change detection are learned via simu-
lation. In this example, the focus is on the latest cumulative effect
of change. The non-restarting CUSUMs is applied here and the
change detection flag is only triggered at the end of the analysis
time period.
Figure 4: Example of Enhanced SPC Algorithms: Non-
restarting CUSUM
Moreover, we attribute the impact of detected cost changes into
multiple explanatory factors as shown in Figure 5.
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Figure 5: Example of Multi-KPI Change Attribution
The impact of change in cost per enrollee is determined by
c(t) = s(t) − s(t −T ), t = T , . . . , P
I (c) = EWA(c(T + 1), . . . , c(P))
where s(t) is the cost per enrollee in period t , and EWA is the
exponential weighted average 1−w1−wP−T
∑P
t=T+1w
P−tc(t).
The total impact of change I (c) could be decomposed by unit
price I (c1) and utilization I (c2) as follows.
c1(t) = e(t −T )[a(t) − a(t −T )], t = T + 1, . . . , P
J (c1) = EWA(c1(T + 1), . . . , c1(P))
c2(t) = [e(t) − e(t −T )]a(t −T ), t = T + 1, . . . , P
J (c2) = EWA(c2(T + 1), . . . , c2(P))
where e(t) is the quantity to enrollee ratio in period t , a(t) is the
unit price in period t .
Let δ1 = [J (c1) + J (c2)] − I (c), the impact due to unit price is
I (c1) = J (c1) − δ1 × |J (c1)|/[|J (c1)| + |J (c2)|],
and the impact of change due to utilization is
I (c2) = J (c2) − δ1 × |J (c2)|/[|J (c1)| + |J (c2)|].
Similarly, the impact of change due to utilization I (c2) could be
further decomposed by treatment intensity, treatment participation
and disease prevalence.
As an example, Figure 5 shows the trends and confidence inter-
vals of KPIs for Trulicity, a drug indicated for patients with type 2
diabetes. The KPI trends indicate that the cost increase of Trulicity
is driven by an increase in utilization, particularly treatment partic-
ipation. The total cost impact of Trulicity for treating diabetes has
increased $0.1087 per member per month (PMPM), among which
only $0.0098 (9.0%) is due to unit price increase and the remaining
$0.0989 (91.0%) is attributable to increases in utilization. Further
decomposing the cost impact of utilization, treatment participation
attributed to $0.1044 increase PMPM, while treatment intensity
only accounts for $0.0073 increase. Conversely, the cost impact is
reduced by $0.0129 due to lower prevalence of types 2 diabetes over
time.
3.2 Characterize Change Patterns
In order to turn the time-series results into interpretable themes
or categorizations, we use a multi-resolution temporal aggregation
scheme.
Table 1: Rule-based Profiling for Change Pattern Character-
ization
Change patterns Short time window Long time window
Emerging growth increase no change
Emerging decline decrease no change
Persistent growth increase increase
Persistent decline decrease decrease
Stabilizing growth no change increase
Stabilizing decline no change decrease
The change detection algorithm described in Section 3.1 is exe-
cuted on different analysis time windows (e.g., 2-year short-term vs.
5-year long-term window). Depending on the time windows, time
series data are aggregated by different resolutions (e.g., 3-month vs.
6-month granularity for short and long run, respectively). Machine
learning classifiers (e.g., rules-based, neural net, etc.[4]) or unsuper-
vised classifiers (e.g., clustering, etc.[4]) could then be employed to
assign shapes of change into characterized detection patterns.
Table 1 shows an example using rules-based methods to char-
acterize the change patterns according to the results of multi-
resolution analysis. Short-run high resolution analysis and long-run
low resolution analysis results are analyzed for various changes.
As shown in Table 1, short-run and long-run results may reveal
different change patterns, for example, emerging growth (recent
increasing change) or persistent decline (long-term continued de-
creasing change).
4 UTILIZATION OFFSETS
4.1 Identify Offsetting Treatments
The offsets are identified when utilization patterns of the compara-
ble factors under the same condition move in opposite directions
within the same time window.
Offsets may include drug treatments, place of services, disease
severity, etc. Potential substitutions of drugs within the same thera-
peutic class and indication per published evidence may be analyzed
using Micromedex RED BOOK database. Shifts in care settings may
also be identified as well as shifts in disease severity stages.
Figure 6 shows an example of MOD identification for type 2
diabetes. The prevalence (patients to enrollee ratio) of diabetes
type 2 is decreasing. An MOD group is identified with an increase
in utilization for Rx Pharmacy, and a decrease in utilization for
Outpatient services. This indicates a potential treatment shift from
outpatient to drugs. Although the therapeutic class “Antidiabetic
Agents, Insulins” shows a decrease in utilization, further drill downs
reveal that the utilization of Trulicity is increasing while utilization
of Janumet, Glumetza and Metformin HCL is decreasing. Note that
Janumet and Glumetza are brand name drugs for Metformin HCL,
which is also detected. Trulicity’s active ingredient is a different
compound (glucagon-like peptide-1 receptor agonist) and is admin-
istered via injection compared to the other oral medications. Our
MOD analysis indicates a treatment shift for type 2 diabetes in this
population and we quantify the impact of this observed shift.
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Figure 6: Diabetes Type 2 Hierarchical Drill Paths
4.2 Estimate Treatment Offset Cost Impact
Offset tracking can be accomplished at different granularities, from
population-level to individual-level. Our approach focuses on esti-
mating the impact using population-level data which reduces the
analytic complexity.
We define an offsetting network including originators (treat-
ments with decreased utilization) and receivers (treatments with
increased utilization). The utilization migration within the offset-
ting network and external factors are difficult to track at the pop-
ulation level; we cannot distinguish individuals who are existing
versus new or discontinued patients for a treatment. We only have
information on the total usage of the treatment at sub-population
level, which poses challenges to accurately estimate the utilization
migration. To determine the volume of utilization migration ex-
cluding the effects of new/discontinued patients, we postulate the
following assumptions.
Proportional Allocation Assumptions. (a) The volume of outflow
offset from a treatment option that experiences utilization decrease
(originator) to a comparable treatment option that experiences
utilization increase (receiver) is assumed to be proportional to the
amount of observed utilization increase of the receiver. (b) The
total volume of outflow offset from an originator is assumed to be
proportional to the amount of observed utilization decrease of the
originator.
Migration Equilibrium Equations. The offset inflow of a receiver is
equal to the total offset outflow received from all of its originators.
Maximum Migration Principle. The outflow offset volumes from
originators to receivers are determined by maximizing the total
amount of outflow offset from all originators under the constraints
of proportional allocation. The inflow offset volume of each receiver
is determined by summing the outflow volumes from all originators.
Utilization migration for each treatment options within the net-
work can be calculated based on Algorithm 1. The cost impact due
to offset can be computed by using offset-adjusted utilization under
the assumption of no change in average cost. In our example, Trulic-
ity substituting Metformin-based drugs resulted in a cost increase
of $0.2720 PMPM for treating type 2 diabetes.
5 CONCLUSIONS
In this paper, we present a systematic approach that detects cost
change drivers within large-scale healthcare claims data using hi-
erarchical and multi-resolution search strategies. Our approach
Algorithm 1: Algorithm of Calculating MOD Impact
Input: An offseting network with outflow o1, . . . ,oI from the
originators O1, . . . ,OI and inflow r1, . . . , r J to
receivers R1, . . . ,R J .
Output: Offset outflow om,1, . . . ,om, I and offset inflow
rm,1, . . . , rm, I .
1 Estimate the population of migrations that satisfies Maximum
Migration Principle and the migration constrains
Pm = min
[∑I
i=1 oi , 1/
(∑I
i=1
oi∑
R(oi )∑Ii=1 oi
)]
2 Given migration population Pm , calculate within-network
migration from each originators om,1, . . . ,om, I based on
Proportional Allocation assumptions (b).
3 Calculate migration transitions (Oi → R(Oi )) based on
Proportional Allocation assumptions (a).
4 Calculate migration to each receivers rm,1, . . . , rm, I based on
Migration Equilibrium Equations.
provides data scientists and payers an early-warning alert sys-
tem to surface emerging cost drivers to support early intervention
for healthcare cost management. We highlight changes in cost
outcomes attributing these changes into actionable and clinically
meaningful factors. This approach could also be applied to differ-
ent settings including monitoring changes in healthcare quality or
other performance-based metrics.
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